The MAPK pathway has been shown to interact with PDE4D (Hoffmann et al., 1999, Sheppard et al., 2014, Zhang et al., 2004), but to date has not been associated with other PDE4 subfamilies and anxiety, providing new opportunities for treating anxiety. This evidence concerns the gene PDE4A and Anxiety.